Compare CVE & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CVE | TEVA |
|---|---|---|
| Founded | 2009 | 1901 |
| Country | Canada | Israel |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.0B | 40.5B |
| IPO Year | 2009 | 1996 |
| Metric | CVE | TEVA |
|---|---|---|
| Price | $31.12 | $36.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $30.50 | ★ $38.63 |
| AVG Volume (30 Days) | ★ 6.7M | 5.5M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.03% | N/A |
| EPS Growth | N/A | ★ 183.45 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.74 | $2.97 |
| P/E Ratio | $18.07 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.77 | $17.33 |
| 52 Week High | $32.07 | $37.39 |
| Indicator | CVE | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 65.36 | 66.67 |
| Support Level | $27.51 | $30.42 |
| Resistance Level | $32.07 | $37.17 |
| Average True Range (ATR) | 0.91 | 1.04 |
| MACD | 0.16 | 0.34 |
| Stochastic Oscillator | 91.77 | 88.48 |
Cenovus Energy Inc is a Canadian integrated energy group. The group's upstream operations include oil sands projects in northern Alberta; thermal and conventional crude oil, natural gas, and natural gas liquids (NGLs) projects across Western Canada; crude oil production offshore Newfoundland and Labrador; and natural gas and NGLs production offshore China and Indonesia. Its downstream operations include upgrading and refining operations in Canada and the U.S., and commercial fuel operations across Canada. The group's reportable segments are: Oil Sands, Conventional, Offshore, Canadian Refining, U.S Refining, and Corporate and Eliminations. Maximum revenue is generated from its Oil Sands segment. Geographically, the group derives maximum revenue from the U.S., followed by Canada and China.
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.